phase readout
saveNCT07000357: A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RECRUITINGupdated 9d ago
community read0 votes
Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Cardiovascular Disease
view source ↗
comments(0)
5-min edit window · permanent after that